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Abstract
Background: This paper provides empirical evidence on how the relationship between health expenditure and
health outcomes varies across countries at different income levels.
Method: Heterogeneity and cross-section dependence were controlled for in the panel data which consist of 161
countries over the period 1995–2014. Infant, under-five and maternal mortality along with life expectancy at birth
were selected as health outcome measures. Cross-sectional augmented IPS unit root, panel autoregressive distributed
lag, Dumitrescu-Hurlin and Toda-Yamamoto approach to Granger causality tests were used to investigate the relationship
across four income groups. An impulse response function modelled the impact on health outcomes of negative shocks
to health expenditure.
Results: The results indicate that the health expenditure and health outcome link is stronger for low-income compared
to high-income countries. Moreover, rising health expenditure can reduce child mortality but has an insignificant
relationship with maternal mortality at all income levels. Lower-income countries are more at risk of adverse impact on
health because of negative shocks to health expenditure. Variations in child mortality are better explained by rising
health expenditure than maternal mortality. However, the estimated results showed dissimilarity when different
assumptions and methods were used.
Conclusion: The influence of health expenditure on health outcome varies significantly across different income levels
except for maternal health. Policymakers should recognize that increasing spending has a minute potential to improve
maternal health. Lastly, the results vary significantly due to income level, choice of assumptions (homogeneity, cross-
section independence) and estimation techniques used. Therefore, findings of the cross-country panel studies should
be interpreted with cautions.
Background
Over the past few decades the world has seen substantial
improvements in health outcomes (HO). This has
coincided with rising health expenditure (HE). Global per
capita HE has increased from US$587 in 2000 to US$1299
in 2015 in real terms [1]. Globally, since 1990 to 2013, the
under-five mortality rate (U5MR) decreased by 49%, the
reduction in maternal mortality ratio was 45% and life
expectancy at birth (LFE) increased from 64 years to
71 years [2].
A large literature has examined the variations in HO
and HE across countries [3–6]. Despite these efforts the
causal relationship between HE and HO is still not clear.
Researchers are yet to confirm whether income plays a
key moderating role in deciding the direction of causality.
Moreover, past empirical studies have overlooked the im-
pact on HO due to a negative shock to HE. The question
remains: how much variation in HO can be explained by
HE? Equally important is to understand the effect of the
assumptions of homogeneity and cross-section independ-
ence on the empirical findings of earlier studies. Lastly,
wide disagreement regarding the variables which most
accurately measure HO exists [7, 8].
It is usually assumed that rising HE will automatically
improve HO. Nonetheless, the evidence for a causal
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association between the two variables remains inconclu-
sive. Some studies have found no causal relationship or
an insignificant association [6, 9]. Gupta et al. [10] sam-
pled 50 developing and transition countries for 1993 and
1994 and concluded that increased HE reduces IMR and
the under-five mortality rate (U5MR). Crémieux et al.
[11] found that lower HE was associated with increased
IMR and decreased LFE in selected Canadian provinces.
Other panel data studies have found a significant associ-
ation and concluded that HE plays an important role in
improving HO [12, 13].
Other studies have found no evidence that total HE has
any significant impact on HO [9, 14, 15]. Therefore, whether
HE can significantly influence the different measures of HO
remains unclear, and warrants further investigations.
Past studies have shown contradictory findings on the
scale of association across low and high-income countries.
Bradley et al. [16] and Gupta et al. [10] concluded that
public HE provides a higher return to HO for poor coun-
tries than for high-income countries. Similarly, Self and
Grabowski [17] found that HE has a significant impact on
health only in low and middle-income countries. Further-
more, Bidani and Ravallion [18] and Nicholas et al. [19]
stated that public HE is useful for the poor but not for the
non-poor (high-income) in improving HO. Nicholas et al.
[19] also concluded that private HE has no significant
impact in reducing child and maternal mortality in 40
countries of sub-Saharan Africa. Similar results were also
found by Anyanwu and Erhijakpor [20] for 47 African
countries and Farag et al. [12] for 133 low and middle
income countries. Contradicting these findings, Hall et al.
[13] examined OCED countries, Jakovljevic et al. [21] with
24 European Union countries and Vavken et al. [22] with
selected European Union countries all concluded that HE
has had a significant impact on HO. Again, Bokhari et al.
[23] in developing countries found a significant relation-
ship between HE and maternal mortality rate (MMR).
Nixon and Ulmann [5] indicated that HOs are signifi-
cantly influenced by factors like diet, lifestyle and the
environment. These differ significantly amongst high and
low-income countries, subsequently, the influence of HE
on health should also vary. Therefore, drawing a conclu-
sion as to whether HE influences HO equally at all income
levels is still not clear.
Noticeably, the literature suffers from several methodo-
logical shortcomings. This study will make some significant
methodological contributions to overcoming that deficit.
Firstly, no previous studies have used a comprehensive
sample of panel data over a substantial time period and a
large number of countries, representing all income levels
and regions. Previous studies either used a small number of
countries or smaller time periods. Again, the time series
and panel analyses in earlier research assumed homogen-
eity and cross-section independence in the data [17, 24].
However, these assumptions are not always valid for panel
data analyses. The results of these studies are not robust if
they fail to account for unobserved heterogeneity [25].
Moreover, the presence of cross-section dependence in
panel data can seriously compromise the stationarity of the
variables and cause the regression results to be spurious
[26]. This issue will be addressed by using recently devel-
oped estimation techniques (cross-sectional augmented IPS
(Im-Pesaran-Shin) test and Dumitrescu-Hurlin (DH)
causality test for heterogeneous panel) to overcome this
problem. Lastly, no previous study has examined the
impact on HO of negative shocks to HE. Impulse response
function (IRF) and forecast-error variance decomposition
(FEVD) tests are innovative methods for finding sources of
information and transmission of information in a dynamic
panel analysis [27]. Therefore, these tests will be employed
to understand the responsiveness of HO to negative shocks
in HE at different income levels.
The objective of this study is to examine these relation-
ships using a comprehensive data set of 161 countries,
divided into four income groups (see Appendix). By com-
paring the respective conclusions from each income
group, it will be possible to examine the moderating role
of income on the HE-HO nexus. Robustness of results will
be enhanced by using new, appropriate estimation tech-
niques at each stage. To the best of authors’ knowledge,
no previous studies examined the HO and HE relationship
using panel data have utilised these techniques. Lastly, an
examination of which of four HO measures (IMR, U5MR,
MMR and LFE) are more responsive to changes in HE at
different income levels will be made.
This paper has of five sections. After this introductory
part, the method and model structure, data and estimation
strategy is presented in section “Methods”. Section
“Results” reports the results whilst a discussion and some
policy implications of these are presented in section
“Discussion”. Lastly, section “Conclusions” will offer
conclusions and outline some limitations of the study.
Methods
Model structure
The model structure has been derived from the Grossman
demand for health model [28].
The Grossman model specifies the gross investment in
stock of health with the following equation,
It ¼ It Mt;THt; Etð Þ
In the above equation, Mt,THt and Et imply medical care,
time input in gross investment function and stock of
human capital, respectively. Any changes to these variables
also changes the net investment in stock of health. None-
theless, medical care, being the most important market
good component of the gross investment function [28], has
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prices and costs associated with it. Therefore, holding other
things constant, higher utilisation of medical care is related
to higher health care expenditure (HE) and vice versa.
Hence, the volume of medical inputs used is a function of
the level of HE,
Mt ¼ f HEtð Þ
Therefore, the current study assumes that with the
growth of per capita health expenditure, health status or
outcomes also increases, significantly.
Data
A heterogeneous panel data method for investigating the
causal relationship between HE and HO is adopted. The data
is annual for 161 countries for the period 1995 to 2014. The
source of the data set are the World Development Indicators
[1] and the Global Health Observatory [29]. HE per capita
was used as the predictor variable for the cointegration tests.
Four variables will be used as a proxy for measuring HO
following the previous studies of Wang [30], Bokhari et al.
[23] and Anyanwu and Erhijakpor [20]. The variables are
infant mortality rate (IMR) per 1000 live births, under-five
mortality rate (U5MR) per 1000 live births, maternal mortal-
ity ratio (MMR) per 100,000 live births and life expectancy
(LFE) at birth. Due to the unavailability of reliable data, other
measures of HO like ‘quality-adjusted life years’ or ‘potential
years of life lost’ were not used.
Table 1 provides a brief comparison of the changes in
values of the variables from 1995 to 2014. Noticeably,
during these 20 years, real HE per capita increased almost
three fold, LFE increased by more than seven years, IMR
and U5MR reduced by half, and MMR has reduced by
approximately two-fifths.
Estimation strategy
The objective of this study is to extend the existing know-
ledge by using a heterogeneous panel data analysis instead
of a homogenous approach, along with the assumption of
cross-section dependence. Diagnostic tests confirmed that
measures of HO (IMR, MMR, U5MR and LFE) and HE
data contain heterogeneity and indicate a cross-section
dependence problem.
Cross-section dependence and heterogeneity in panel data
Cross-section dependence generally arises when the
error-terms of the adjacent units (country, company or
state) are correlated, often due to spillover effects [31] or
unobserved common factors [32]. Many previous studies
have investigated the issue of cross-section dependence in
panel data and cautioned against ignoring the problem
[33]. The issue can create considerable difficulty for the unit
root test [26], and may lead to inaccurate estimates [34]
and biased standard errors [35]. There are several reasons
(spatial correlation, distance, and common unobserved ele-
ments) which may be responsible for the dependence [36].
Panel data studies with N>T often fail to provide evidence
for the homogeneity of the pooled data [37] which means
that observations from the identical units tend to be much
more similar compared to the observations of different units
[38]. According to Hauck and Zhang [39] common omitted
variables or events such as, global shocks impact each obser-
vational unit asymmetrically. The presence of heterogeneity
creates a minor nuisance for inferences [31] and may lead to
inconsistent estimates of the parameters [40].
Panel unit root tests
In the first step of the analysis, the stationarity of the data
have been examined with the cross-sectional augmented
IPS (CIPS) unit root tests [41]. The third generation unit
root test allows heterogeneity of the autoregressive
coefficients and gives consistent results in the presences of
cross-section dependence in the panel data [42]. In
addition, the HT (Harris-Tsavails) panel unit root test was
used [43]. It was developed specifically for data sets with
large (N) and small (T) with the option of controlling
cross-sectional means.
Panel cointegration tests
In the second stage, the autoregressive distributed lag
(ARDL) (mean group) technique was used to understand
the cointegration relationship. According to Pesaran et al.
[44], the ARDL can incorporate the heterogeneous panel
into the error-correction model. The mean group (MG)
estimation technique allows the long-run and short-run
effects to be different and be heterogeneous across panel
units [45]. The ARDL model is expressed as:
Δ HOit ¼ ∅i HOi;t−1 þ HEi;t−1βi þ
Xp−1
j¼1αij ΔHOi;t−1
þ
Xq−1
j¼0∂ij ΔHEi;t− j þ εit þ ∪it
where HO is the dependent variable with lag p and HE is
the independent variable with q number of lags. βi is the
long-run coefficient and ∅irepresents scalar coefficients
Table 1 Summary statistics (Global)
Year 1995 2014 1995 2014 1995 2014
Variables Obs Mean Mean Std.Dev Std.Dev Max Max
HE 161 443.4 1202.5 819.8 1971.8 4308.5 9673.5
LFE 161 54.5 61.7 12.2 10.6 73.5 76.7
U5MR 161 64.5 30.9 65.2 32.6 279.5 162.2
IMR 161 43.7 23.2 37.4 21.8 153.4 98.8
MMR 160 277.9 157.8 403.1 227.2 2900 1410
Source: World Bank (2016)
Notes: Obs Number of observations, Max Maximum value and HE Health
expenditure per capita, LFE Life expectancy at birth, U5MR Under-five mortality
rate, IMR Infant mortality rate and MMR Maternal mortality rate
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on the lagged dependent variable which measures the
speed of adjustment to the long-run equilibrium. ∂ is the
short-run coefficient for independent variable and α is for
the dependent variable. In addition, subscript i and t indi-
cate the country and time indexes of the panel data set
respectively. To determine the lag length, the standard lag
selection criteria of Akaike information criterion (AIC)
and Bayesian information criterion (BIC) were used.
ARDL techniques are used to examine the cointegrating
relationship among variables which are not stationary of
the same order [44, 46].
Further the FMOLS (Fully modified ordinary least
squares) method developed by Pedroni [47] which incor-
porates the semi-parametric correction of the OLS estima-
tion suggested by Hansen and Phillips [48] is also utilised
as the majority of the data are stationary at I(1) and the
approach provides reliable estimates for small samples
[49]. The cointegration system for panel data is:
HOit ¼ β0 þHEitβi þ εit
and
HEit ¼ HEi;t−1 þ vit
where the vector error process ϑit= ( it ; vitÞ is stationary
with asymptotic covariance matrix represented by Ωi .
The variables, HOi and HEi, have long-run cointegration
with cointegrated vector βi, if the HEit is integrated of I(1)
[47]. In addition, FMOLS uses a semi-parametric correc-
tion for endogeneity and serial correlation. Moreover, the
group mean estimator of FMOLS allows for a higher
degree of heterogeneity to be present in the dynamics
underlying dependent and independent variables [50, 51].
Based on Pedroni [47], the FMOLS estimator is:
β^i;FMOLS ¼ N−1
XN
i¼1
XT
i¼1
HEit−HEit
 2 !−1
XT
i¼1
HEit−HEit
 
HOit−T τi
 !
where HOit = ðHEit−HEitÞ−ðΩ^21iΩ^221ÞΔHEit and
τ^i ¼ Γ^21i þ Ω^021i−
Ω^21i
Ω^221
 !
Γ^22i þ Ω^022i
 
where Ω^ represents the covariance and Γ^ indicates the
sums of autocovariance acquired from the long-run
covariance matrix. In addition, τ^i is the moderator to
correct for the autocorrelation which arises from the
heterogeneity dynamics determining dependent and
independent variables in the short run process [49].
Panel granger causality tests
Next, panel causality tests suggested by Toda and
Yamamoto [52] (TY) and Dumitrescu and Hurlin [53]
(DH) were performed. Both are modified versions of the
causality test suggested by Granger [54]. According to
Dumitrescu and Hurlin [53], the heterogeneous panel
causality test is designed for bi-variates models of
stationary and nonintegrated variables. The following
DH non-causality equations were examined:
ΔHOit ¼ ∝þ
XK
k¼1
βikΔ HOi;t−k þ
XK
k¼1
∅ikΔ HEi;t−k þ ∈i;t
ΔHEi;t ¼ ∝þ
XK
k¼1
βikΔ HEi;t−k þ
XK
k¼1
∅ikΔ HOi;t−k þ ∈i;t
where K indicates the number of lag length in the bal-
anced panel with ∝ is the intercept and slope coefficients
are β and∅. As the test is sensitive to lag length [55], the
formula T > 5 + 2X was used to determine the minimum
number of lags where X signifies the minimum number of
time needed at each number of lags and T is the time
period [56]. The modified Wald (MWALD) causality test
proposed by Toda and Yamamoto [52] is also used as it
reduces the probability of inaccurate identification of the
order of integration in the series by ignoring any possibil-
ity of non-stationarity and lack of cointegration in the
panel [57, 58]. The modified Wald equation is:
ΔHOt ¼ α0 þ
Xn
k¼1
α1kΔ HOt−k þ
Xdmax
j¼nþ1
α2 jΔ HOt− j
þ
Xn
k¼1
∂1kΔ HEt−k þ
Xdmax
j¼nþ1
∂2 jΔ HEt− j þ ω1t
ΔHEt ¼ β0 þ
Xn
k¼1
β1kΔ HEt−k þ
Xdmax
j¼nþ1
β2 jΔ HEt− j
þ
Xn
k¼1
∅1kΔ HOt−k þ
Xdmax
j¼nþ1
∅2 jΔ HOt− j þ ω2t
The Toda-Yamamoto test increases the accurate order
of the VAR system, n, precisely to the maximum order of
integration, dmax [58]. Lastly, the approach uses seemingly
unrelated regression (SUR) to estimate the model [59].
These two causality tests (DH and TY approach) are
appropriate given the panel was heterogeneous, stationary
at different levels (in some cases) and not cointegrated in
the long-run for some of the models.
Finally, to measure the impact of an unexpected shock in
the vector autoregressive (VAR) model, IRF and FEVD tests
were performed. According to Swanson and Granger [60],
IRF and FEVD tests proposed by Sims [61] are an integral
part of the VAR estimations. The IRF examines the impact
of shocks in cross-section by tracing the marginal effect of a
shock to one variable in the system for the response variable
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[25]. On the contrary, FEVD shows the fraction of the
changes in the dependent variable that is subject to their
own shocks against the shocks to the impulse variable [62].
For further discussion on the methods of IRF and FEVD
(Sims [61], Lütkepohl and Krätzig [63], and Brooks [62]).
Prior to these tests, the stability condition of the VAR
was checked with the VAR stability test.
Diagnostic tests
To identify serial correlation in the panel data model the
test developed by Wooldridge [31] is used. This test uses
less assumptions, which are more robust and appropriate
for micro panels. To examine the level of cross-section
dependence (CD) in the panel data, the CD test of Pesaran
[64] was performed. The test assumes zero mean for fixed
values of T and N, and appropriate for heterogeneous,
non-stationary and dynamic panel models [65]. In
addition, modified Wald test for group wise heteroscedas-
ticity and residual normality test [66] were conducted.
Results
Panel unit root tests
The results from cross-sectional augmented IPS (CIPS)
and HT panel unit root tests for the level and first
Table 2 Panel unit root test results
Cross-sectional Augmented IPS (CIPS*) (Trend)
Dep.Variables HE IMR MMR U5MR LFE
Income Groups Level 1st Diff Level 1st Diff Level 1st Diff Level 1st Diff Level 1st Diff
GL −2.13 − 3.74* − 2.42 − 3.31* − 2.54 − 4.26* − 2.65 − 2.88* − 2.95* − 3.83*
LY − 2.70 − 4.27* −2.38 − 2.72* − 1.90 − 3.33* −2.04 − 2.71* −2.85* − 2.77*
LM −2.44 − 3.44* − 2.53 −2.98* − 2.09 − 3.16* − 3.23* 3.86* − 3.11* − 3.98*
HM − 2.52 − 3.54* − 2.12 −2.95* − 2.36 − 4.42* −2.17 − 2.96* − 3.98* − 4.13*
HY − 1.49 − 2.94* −2.02 − 3.09* 2.75* − 5.12* − 2.21 − 3.02* − 2.73* − 4.42*
Harris–Tsavalis (HT) (Trend)
Dep. Variables HE IMR MMR U5MR LFE
Income Groups Level 1st Diff Level 1st Diff Level 1st Diff Level 1st Diff Level 1st Diff
GL 5.51 −16.51* 8.52 − 5.42* 12.34 9.13+ − 12.27* −41.78* 13.98 6.05+
LY 1.07 − 13.35* 0.61 − 14.90* 6.02 5.22+ −13.20* − 27.22* 8.87 6.69+
LM 4.17 −12.82* 7.12 5.54+ 5.71 −5.79* 6.09 −7.17* 12.12 10.27+
HM 2.97 −10.25* 5.34 3.62+ 5.92 −3.88* 5.93 3.29 1.68 −4.33*
HY 3.23 −10.26* 6.99 −5.16* − 0.66 − 15.58* 6.88 5.92 4.37 −7.24*
Cross-sectional Augmented IPS (CIPS*) (Constant)
Dep. Variables HE IMR MMR U5MR LFE
Income Groups Level 1st Diff Level 1st Diff Level 1st Diff Level 1st Diff Level 1st Diff
GL −2.20* −3.69* −2.47* − 2.53* −2.42* −3.68* − 2.78* −2.45* − 2.12 −3.17*
LY −3.16* −4.37* −2.78* − 2.45* −1.36 −2.50* − 2.39* 2.31* − 3.33* − 2.88*
LM − 2.82* −3.79* − 2.44* −2.32* − 2.09 −3.17* − 3.23* −2.51* −1.14 −3.10*
HM −3.25* −3.57* −2.30* –2.61* −2.63* −3.80* −2.42* −1.81 −1.87 −4.18*
HY −1.83 −3.41* −2.03* −3.10* −2.75* −4.63* − 2.32* − 3.02* −2.38* − 4.23*
Harris–Tsavalis (HT) (Constant)
Dep. Variables HE IMR MMR U5MR LFE
Income Groups Level 1st Diff Level 1st Diff Level 1st Diff Level 1st Diff Level 1st Diff
GL 11.05 −54.82* 10.16 −64.33* 9.35 −27.68* 6.72 −98.98* 12.27 −27.33*
LY 2.51 −16.51* 8.51 −5.41* 9.34 −27.68* 6.72 −98.97* 6.88 −30.25*
LM 4.17 −12.82* 7.21 −6.35* 3.83 −32.64* 5.27 −27.17* 7.08 1.13+
HM 2.87 −10.16* 5.27 3.57+ 1.51 −5.46* 5.01 −7.91* 6.20 −34.49*
HY 11.05 −54.82* 10.16 −64.32* 9.34 −27.68* 6.72 −98.97* 11.00 −27.33*
Notes: *Significant at the 5% confidence interval. +Not stationary at 1st difference. The optimal lag used for CIPS* test was based on MBIC and MAIC lag selection
criteria. For the CIPS test the results of trend option are presented and the HT test the ‘Demean’ option was used to control for cross-sectional means. Here, HE
Health expenditure per capita, GL Global, LY Low-income, LM Lower-middle, HM Higher-middle and HY High-income countries
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difference series are presented in Table 2. The CIPS hetero-
geneous panel unit root test indicated that HEPC, IMR,
MMR, and U5MR are stationary at first difference. For
higher income group, MMR, and for the lower-middle in-
come group, U5MR is stationary at level. However, LFE is
stationary at level and 1st difference for all income group.
The HT test showed similar results to CIPS in most of
the cases except for the variable LFE. Interestingly, the test
showed IMR for higher-middle and LFE for lower-middle
income countries are not stationary either at level or at first
difference. Based on these test results the ARDL (MG) test
was applied to investigate the long-run association between
the measures of IMR, MMR, U5MR and LFE with HE.
Panel cointegration test
The ARDL test provides efficient estimates when the vari-
ables are cointegrated at dissimilar levels [44, 46] and report
both short-run and long-run relationship between the vari-
ables. The findings in Table 3 indicate mixed results. It can
be seen that IMR and LFE are cointegrated with HE in the
short-run for all income levels. LFE also demonstrated
long-run cointegration. However, MMR is cointegrated in
the short run only for lower-middle and higher income
countries and U5MR for lower-middle income countries.
The long run coefficients showed a different picture. All
the measures of HO have a long-run relationship with HE
for low-income, higher-middle, and high-income countries.
To estimate the robustness of the findings of long-run
relationship the FMOLS approach was employed. The re-
sults of the FMOLS test (Table 4) confirmed the long-run
association between HO and HE. The only exception was
MMR, which indicates no long-run cointegration with HE
for lower and lower-middle income countries. Therefore,
it is concluded that HO and HE were cointegrated in the
long-run, however, the results vary based on the level of
income and measures of HO used.
Granger causality test
After confirming the long-run association, the VAR
Granger panel causality test, the DH panel causality test
and TY approach to Granger causality test were performed.
The DH and TY approaches provide more reliable results
as the panel data is heterogeneous, that is, variables are
stationary at different levels and showed mixed results in
the cointegration relationship.
In the DH causality test, HO and HE indicated
bi-directional causality. Nevertheless, the results differ at
different income levels. There are bidirectional relation-
ships for IMR and U5MR with HE for low-income and
lower-middle income countries. For high-income coun-
tries U5MR has bidirectional causality. The test found
no causality for MMR with HE at any income level.
Again, the TY approach also illustrated bi-directional
causality for IMR and U5MR with HE only for
low-income countries. In addition, there is uni-directional
relationship running from HE to IMR for high-income
and lower-middle income countries. Thus, according to
the TY causality test, HE Granger causes IMR and U5MR
only for low-income countries.
The results in Table 5 indicated that the causal relation be-
tween HE and HO depends on income level, type of variables
used to measure HO and choice of estimation techniques.
Therefore, the results of the past studies that concluded a sig-
nificant causal relationship should be interpreted with caution.
Table 3 Mean group estimation ARDL model
Dep.Variables IMR MMR U5MR LFE
Income Groups Long Short Long Short Long Short Long Short
LY −0.22* (0.04) − 0.01* (0.01) 0.48* (0.14) − 0.11 (0.08) 0.03* (0.04) − 0.03 (0.02) − 0.01* (0.25) − 0.21* (0.03)
LM − 0.01 (0.03) −0.04* (0.01) − 0.02 (0.04) −0.26* (0.09) − 0.01 (0.04) −0.07* (0.16) 0.013* (0.08) −0.44* (0.05)
HM 0.124* (0.02) −0.02* (0.07) 0.05* (0.28) 0.01 (0.08) 0.07* (0.04) −0.03 (0.05) 0.04* (0.00) − 0.51* (0.09)
HY 0.00* (0.00) −0.08* (0.14) −0.01* (0.00) − 0.08* (0.05) 0.00* (0.00) −0.09 (0.15) 0.00* (0.00) −1.15* (0.11)
Notes: Figures in brackets are the standard errors. * Significant at 5% level. Lag order is chosen using AIC criterion. The estimated constant terms are significant at
5% confidence interval for all the model
Table 4 Fully modified ordinary least square (FMOLS) test
Dep. Variables IMR MMR U5MR LFE
Income Groups Coef. SE Coef. SE Coef. SE Coef. SE
GL −0.003* 0.000 −0.024* 0.004 −0.004* 0.001 0.092* 0.006
LY −0.005* 0.001 0.059 0.306 −0.080* 0.047 0.930* 0.180
LM −0.025* 0.003 0.034 0.028 −0.040* 0.004 0.523* 0.085
HM − 0.005* 0.001 −0.100* 0.017 −0.006* 0.002 0.209* 0.020
HY −0.002* 0.001 − 0.036* 0.011 −0.000* 0.000 0.014* 0.003
Notes: * Indicates significant at 5% confidence interval
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Diagnostic tests
Several diagnostic tests were performed to investigate key
characteristics of the data. The diagnostic tests reveals that
the model with LFE (dependent variable) and HE (inde-
pendent variable) has first order serial correlation and the
residuals are not normal. Therefore, no substantive con-
clusion about the relationship between LFE and HE can
be made. Table 6 presents all the results of the diagnostic
tests. The Wooldridge test for autocorrelation rejected the
null hypothesis of first order autocorrelation for all models
at all income levels except for the model of LFE and HE.
The Pesaran CD test significantly accepts the alternative
hypothesis of the presence of the cross-section depend-
ence among the panel data. Moreover, the modified Wald
test also found that the panel data contains heterogeneity.
Lastly, the residual normality test on the panel data accepts
the null hypothesis, therefore, it is concluded that the re-
siduals of the panel data are normally distributed.
A vector autoregressive normality test (not reported)
was also undertaken and all the eigenvalues indicated
that the panel VAR is stable for all models.
Impulse response and variance decomposition tests
The Granger causality test suggested significant impact and
direction of causality among the variables in the model but
the results do not represent the construction or duration of
these impacts. The results of the impulse responses of the
variables are presented in Fig. 1 and variances decomposi-
tions in Table 7. The results of the IRF test indicated that any
shock to HE per capita increases IMR and U5MR but the ef-
fects die down after two to three periods. Interestingly,
MMR, except in low-income countries, reacted negatively to
Table 5 Granger causality and non-causality tests
Granger causality test DH non-causality approach TY non-causality approach
HE to IMR IMR to HE HE to IMR IMR to HE HE to IMR IMR to HE
Z-value Z-value Z-value Z-value Z-value Z-value
GL 2.91 14.37* 9.29* 10.31* 6.69 7.32
LY 7.77* 0.43 3.19* 5.97* 4.57* 12.31*
LM 4.25 14.10* 3.02* 3.06* 5.79* 1.94
HM 2.88 1.92 1.54 1.65* 1.74 6.01
HY 22.57* 30.64* 4.02* 1.22 12.21* 5.79
Granger causality test DH non-causality approach TY non-causality approach
HE to MMR MMR to HE HE to MMR MMR to HE HE to MMR MMR to HE
Z-value Z-value Z-value Z-value Z-value Z-value
GL 5.76 10.67* 3.65* 4.01* 4.12 3.35
LY 0.20 1.07 −1.64 1.20 9.43* 1.95
LM 2.34 0.46 0.11 −0.84 5.29 5.89
HM 0.91 0.54 −0.24 − 0.12 5.39 0.01
HY 2.85* 0.56 −0.97 1.78* 1.87 6.37
Granger causality test DH non-causality approach TY non-causality approach
HE to U5MR U5MR to HE HE to U5MR U5MR to HE HE to U5MR U5MR to HE
Z-value Z-value Z-value Z-value Z-value Z-value
GL 7.97* 22.07* 9.26* 12.06* 5.52 5.02
LY 12.61* 0.55 4.51* 5.115* 10.19* 13.75*
LM 8.19* 1.49 4.36* 6.62* 1.67 1.65
HM 0.82 0.23 1.02 1.103 2.88 5.98
HY 35.58* 26.51* 3.82* 2.001* 3.27 3.44
Granger causality test DH non-causality approach TY non-causality approach
HE to LFE LFE to HE HE to LFE LFE to HE HE to LFE LFE to HE
Z-value Z-value Z-value Z-value Z-value Z-value
GL 11.85* 14.33* 16.30* 22.60* 52.21* 24.92*
LY 0.59 0.21 2.73* 31.17* 2.85 4.02
LM 2.30 0.28 2.18* 10.13* 5.2 14.04*
HM 1.32 0.56 1.78 37.38* 10.46 13.42*
HY 0.00 1.28 13.25* 19.62* 33.34* 5.21
Notes:* Indicates significant at 5% confidence interval. Lag lengths based on Modified AIC and Modified BIC lag selection criteria
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any shock to HE. Expectedly, the results showed that HO of
low-income countries are more vulnerable to any shock in
the model. Again, any shocks to HE have more impact on
U5MR than the other measures of HO.
The results in Table 7 are consistent with the findings of
the IRFs and reveal that HE can explain future variations in
U5MR more than any other measures of HO at all income
levels. HE can explain as much as 17.21% of the variation
in IMR after the 12th year for low-income countries. Re-
sults of the FEVD test showed that the relationship between
MMR and HE is insignificant at all income levels.
Robustness to alternative specifications
To examine the robustness of the findings, this study esti-
mated two alternative hypotheses by adding a variable to
the model and by identifying the impact of a common
shock on the relationship. First, the ARDL and FMOLS
tests were conducted by incorporating total factor
productivity (TFP) into the model. Previous studies have
concluded that improvement in TFP has a positive and
significant influence on HO [67, 68]. A higher level of TFP
indicates the efficiency with which resources are utilised
[69]. Hence, countries with higher TFP often produce better
HO with lower spending on health. The results (Tables 8
and 9 in Appendix) showed no significant difference in the
association between HE and HO when TFP was controlled
for except for the variable MMR. HE and MMR demon-
strated a significant and negative relationship for lower,
lower-middle and higher-middle income countries. For
detailed definition of TFP and the source of data see the
‘Conference Board Total Economy Database’ [70].
Second, previous studies have concluded that the
global financial crisis (GFC) of 2008 had a severe impact
on health, health-related behaviours and quality of life.
There is evidence to support this link for both developed
countries [71, 72] as well as for developing countries
[73, 74]. These studies associated the GFC with a reduction
in health funding and subsequent poor HO in the post
GFC period. Hence, this study further investigated the
long-run relationship between HE and HO by dividing the
panel data into pre (1995–2008) and post (2009–2014)
GFC periods. The outcomes of panel ARDL model and the
FMOLS estimations for the two periods illustrate minor
differences in the long-run relationship between HE and
HO for middle-income countries (Tables 10 and 11 in
Appendix). In particular, for the lower-middle and
higher-middle income countries the IMR and U5MR show
substantial long-run association with HE in the post GFC
period only.
Table 6 Key diagnostic tests
Wooldridge test for autocorrelation
HE -IMR HE-MMR HE –U5MR HE-LFE
Z-value p-value Z-value p-value Z-value p-value Z-value p-value
GL 2.54 0.113 0.84 0.359 3.76 0.054 27.97 0.000
LY 7.12 0.067 4.92 0.073 3.36 0.075 62.56 0.000
LM 1.39 0.243 1.46 0.232 5.16 0.068 1.13 0.293
HM 2.54 0.112 0.845 0.359 3.75 0.054 0.392 0.532
HY 3.74 0.056 0.092 0.763 12.76 0.081 15.89 0.000
Pesaran CD test Modified Wald heteroscedasticity test
HE to IMR HE-MMR HE –U5MR HE-LFE HE to IMR HE-MMR HE –U5MR HE-LFE
Z-value Z-value Z-value Z-value p-value p-value p-value p-value
GL 0.45* 0.25* 0.48* 0.86* 0.000 0.000 0.000 0.000
LY 0.45* 0.37* 0.43* 0.54 0.000 0.000 0.000 0.000
LM 0.54* 0.29* 0.56* 0.89* 0.000 0.000 0.000 0.000
HM 0.46* 0.23* 0.49* 0.26* 0.000 0.000 0.000 0.000
HY 0.41* 0.72* 0.45* 0.68* 0.000 0.000 0.000 0.000
Residual Normality test
Skewness Kurtosis
p-value p-value
IMR- HE 0.273 0.167
MMR-HE 0.095 0.205
U5MR-HE 0.774 0.165
LFE-HE 0.756 0.002
Notes:* Indicates significant at 5% confidence interval
The null hypothesis for the: Wooldridge test is Ho: no serial correlation; Pesaran CD test is Ho: no cross-sectional dependence; MWALD heteroscedasticity test is
Ho: Presence of homoscedasticity or constant variance. Residual normality test is Ho: Residuals are normally distributed
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Discussion
The findings indicated that the causal relationship varies
significantly between low, middle and high-income
countries. Several major discussion points arise.
First, the causal link between HE with IMR and U5MR is
greater for low-income countries. Although there is evidence
of a significant association at all income levels, the results are
more consistent for low-income countries across all the mea-
sures of HO. These findings are similar to Self and Grabow-
ski [17] and Deaton [75] who concluded that rising HE has
greater influence on HO in low-income countries than in
higher income countries. In addition, high-income countries
have better HO because they continuously enjoy better
health over a longer period of time. As IMR is already at
minimum levels in these countries, rising HE has no signifi-
cant influence on its further reductions.
Second, HE has no causal relation with MMR. Therefore,
countries need to focus on other unobserved variables to
make a substantial impact in its reduction. Gottret and
Schieber [76] and Nicholas et al. [19] also reached similar
conclusions. Compared to child mortality which is an out-
come of primary care, MMR is viewed as secondary care
which is often provided by hospitals [23]. In low-income
countries, especially in rural areas, the lack of infrastructure
and distance to the nearest hospital reduce access to health
care services. Wagstaff [77] found that the quality of the road
network can influence the impact of HE on HO. In addition,
it is accepted that a lack of family planning and minimum ac-
cess to health care are the major causes of MMR [17]. Again,
a closer look at the data reveals that MMR in high-income
countries is already very low, averaging 10 deaths per
100,000 live births. Subsequently, further spending may not
a
b
c
Fig. 1 Impulse response functions. Health expenditures (impulse variable) and health outcomes (response variable). a) Title: IRF (impulse HEPC
and response IMR). Legends . b) Title: IRF (impulse HEPC
and response U5MR). Legends . c) Title: IRF (impulse HEPC
and response MMR). Legends
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induce any significant reduction in MMR. A further analysis
of the relationship indicated that the relationship became sig-
nificant for all income groups except high-income countries
once TFP is accounted for in the model.
Third, ARDL and FMOLS test results indicated that HE
has a positive impact on LFE in the short-run as well as in
the long-run. Similar findings are evident from [14, 21].
Noticeably, the impact of HE on LFE is higher in lower
income countries compared to higher income countries
with better LFE. Therefore, the marginal return of HE on
LFE diminishes as the LFE grows higher.
Lastly, any negative economic shock in HE affects HO
in the low and lower-middle income countries to a
proportionally greater extent. That means, poor coun-
tries are more exposed to negative shocks. In addition,
HE can explain variations in IMR and U5MR more than
the other two measures of HO.
The variations in the relationships between HE and HO
among income groups may be subject to differences in the
health financing mix and level of efficiency in allocating
scarce resources and providing health care services [78].
According to Self and Grabowski [17] developed countries
often enjoy the virtuous cycle of good health because of
higher incomes and levels of education. Previous studies
have also indicated that efficient health interventions and
ease of access to health care services often play a moderat-
ing role in shaping the effectiveness of the health care ex-
penditure [14, 77]. Unfortunately, these measures vary
significantly among countries of different income groups.
In addition, heterogeneity in the HO of the population
often results from lifestyle choices (consumption of
alcohol and tobacco) [79]; obesity and other chronic
diseases [80]; inequality in income distribution; level of
female education; ethnic diversity, and religious beliefs
[14]. Others have concluded that the magnitude of the
association between HE and HO depends on the availabil-
ity and allocation of medical resources [81, 82] and the
efficiency with which these resources are utilized [83]. For
lower and middle-income countries, increases in HE on
immunization and vaccination programs can substantially
reduce child mortality [29, 84]. Another key issue is to
realize that there is evidence of diminishing marginal
returns to growing HE in the health care sector for devel-
oped countries [85]. This indicates that identical amounts
of HE in lower and middle-income countries would gener-
ate higher HO compared to higher income or developed
countries [5]. Hence, the findings in this current study of
significant heterogeneity in the relationship between HE
and HO across income levels is justified.
Lastly, the results depend on the choice of assumptions
made including, homogeneity, cross-section independence,
serial correlation and residual normality. Again, the findings
vary substantially on the selection of lag values, therefore,
like other macroeconomic variables, measures of HO also
depend on their values in previous years. Moreover, in-
appropriate diagnostic tests may lead to incorrect selection
of estimation techniques and spurious results.
Some important policy implications can be drawn from
the findings of the study. Firstly, the marginal impact of
additional per capita health expenditure decreases as the
level of expenditure increases. This is evident from the
empirical results as a dollar increase in health expenditure
Table 7 Forecast-error variance decomposition test (income group comparison)
Variance decomposition Impulse variable health expenditure
LY Response variables LM Response variables
Period IMR MMR U5MR Period IMR MMR U5MR
0 0 0 0 0 0 0 0
2 0.1516875 0.0168 0.083523 2 0.019212 0.006631 0.062427
4 0.1717245 0.0408 0.083659 4 0.022824 0.016638 0.06754
6 0.172093 0.0508 0.083663 6 0.02724 0.020663 0.068715
8 0.1720995 0.005505 0.083663 8 0.030114 0.022065 0.068956
10 0.1721 0.0057 0.083663 10 0.031903 0.02254 0.069006
12 0.1721 0.005795 0.083663 12 0.033052 0.0227 0.069017
HM Response variables HY Response variables
Period IMR MMR U5MR Period IMR MMR U5MR
0 0 0 0 0 0 0 0
2 0.0094175 0.008848 0.014273 2 1.69E-05 0.003191 0.12657
4 0.083379 0.011133 0.046812 2 0.041963 0.019582 0.161816
6 0.102849 0.011687 0.057516 2 0.061122 0.030531 0.213393
8 0.1067585 0.01194 0.062043 8 0.074016 0.047492 0.227842
10 0.1075825 0.012068 0.064321 10 0.082359 0.061703 0.232503
12 0.1077575 0.012136 0.065539 12 0.087124 0.07372 0.23381
Here, GL Global, LY Low-income, LM Lower-middle, HM Higher-middle and HY High-income countries
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in low-income countries demonstrates a greater increase in
health outcomes, compared to higher income countries.
Another important consideration is that mortality rates in
developed countries are considerably lower consistent with
a higher level of life expectancy. Therefore, these countries
need to allocate additional funds (much larger than low or
middle-income countries) for further improvement in
health outcome as their population ages. Secondly, lower in-
come countries are more adversely affected by negative
shocks in the health care sector. Policymakers in these
countries should maintain additional provisions for these
shocks (disease or finance). Else, the health outcome
achievements of one decade might be dissipated within a
very short period of time. Thirdly, the descriptive analysis
showed that countries of all income levels have experienced
lower mortality and rising life expectancy during the last
two decades. This indicates that low and middle-income
countries will soon experience a change in their demo-
graphic structure. Existing financial mechanisms might be
inadequate to support the additional demand for medical
services that will arise. Lastly, lack of adequate information
on health, especially in the low-income countries often
makes it difficult to conduct empirical analysis and draw ac-
curate conclusions. Governments in each country should
devote resources towards high quality health data collection
and make it available for further empirical investigation.
Future empirical studies should focus on analysing the
relationship between health outcomes and expenditure,
using country-specific data. Specifically, understanding
the mediating role of good governance, level of infrastruc-
ture development, productivity, economic development
and health financing mix to explain the impact of health
expenditure on health outcomes.
This study also has some limitations. First, due to data
unavailability the time period studied is relatively short at
20 years; second, the unavailability of a comparable health
index as proxy for HO; third, an accurate causality test on the
relationship between LFE and HE could not be made as the
data showed autocorrelation; fourth, the exclusion of key de-
terminants of HO; and finally, no control for country specific
key factors influencing HO at different levels of income was
undertaken. Moreover, from the methodological perspective,
this study attempted to address some of the common
problems associated with panel cointegration and panel VAR
Granger causality tests. For instance, the issues of stationarity
and heterogeneity of the data and cross-section dependence
have been accounted for with appropriate estimation tech-
niques using a strongly balanced panel data. Nonetheless, the
results of this study should be interpreted with caution due to
some underlying assumptions of the estimation techniques.
For example, the Toda-Yamamoto test fails to distinguish
between short-run and long-run causality [86] and the
cross-section panel data does not take into account the
country-specific characteristics (population, geography,
governance and productivity) [87]. Due to the bivariate
causality model, there may be the possibility of omitted
variable bias. These issues are for future empirical research.
Lastly, this study did not account for measurement errors
in the dependent and explanatory variables. Despite the ability
of panel data to account for measurement errors [88], ignor-
ing the problem especially in the explanatory variables might
generate biased and inconsistent OLS estimates [31, 37, 89].
Gujarati [90] stated that a perfect solution to measurement
errors in the panel data is unavailable however, there are
some suggestions in the literature to account for the problem
in the econometric analysis with an instrumental variable
approach [89] and ‘Generalised Methods of Moments’
estimation [31, 37]. Therefore, future studies may use these
methods to examine the association between HE and HO.
Any variations in findings may prove the presence of meas-
urement error in the HE data produced by the World Bank.
Conclusions
This study examined the relationship between HO and HE
for 161 countries for the period of 1995 to 2014. The findings
from the panel cointegration test reveal that the HO mea-
sures are significantly associated with HE both in the short
and long run and across all income levels. However, the
short-run relation is stronger. More importantly, the hetero-
geneous panel DH causality test indicated that IMR and
UM5R have bidirectional relationships with HE for all
income levels except higher middle-income countries. How-
ever, according to the TY causality approach, HE Granger
causes HO only for the low-income countries. This indicates
that income does play an important moderating role in deter-
mining how much HE influences HO. However, the findings
vary significantly due to the choice of estimation techniques.
In addition, lower income countries are more at risk of
adverse HO because of negative shocks to HE. Variations
in IMR and U5MR are better explained by HE than
MMR. Lastly, the diagnostic test results vary significantly
due to the choice of assumptions and lag order selection.
It is evident from the findings that increasing HE alone
will not generate maximum HO at any income level. The
policy makers need to look into the mix of HE and the al-
locative efficiency of the utilised resources [12, 78]. There-
fore, countries have the potential to achieve better HO
through an efficient composition of HE and its financing
mix. For example, rising HE has an insignificant impact
on reducing MMR. Therefore, for better outcomes policy
makers should focus on effective interventions such as
family planning, increasing productivity of the health care
sector and access to affordable health care. Again, theoret-
ical and empirical research is needed to analyse the
composition of HE and to build a comparable measure of
HO for all countries. Improved/better HO measures like
quality adjusted life years and potential years of life lost
should be widely available.
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Appendix
Table 9 Fully modified ordinary least squares test (with total factor productivity)
Income
groups
Independent
variables
IMR MMR U5MR LFE
Coef. SE Coef. SE Coef. SE Coef. SE
LY HEPC −0.02 0.03 −0.59* 0.29 0.24* 0.06 0.04* 0.01
TFP 0.77* 0.03 −1.12* 0.04 −0.32* 0.08 0.74* 0.02
LM HEPC −0.03* 0.00 0.01 0.04 −0.04* 0.01 0.02* 0.002
TFP 0.18* 0.02 0.29* 0.02 0.46* 0.03 0.18* 0.009
HM HEPC −0.01* 0.00 0.03* 0.003 −0.02* 0.00 −0.003 0.001
TFP −0.16* 0.12 0.15* 0.06 −0.17* 0.02 −0.14 0.014
HY HEPC −0.00 0.00 0.001* 0.00 −0.00* 0.00 0.003 0.000
TFP −0.18* 0.00 −0.30* 0.01 −0.22* 0.01 −0.59 0.012
Notes: * Indicates significant at 5% confidence interval. Coef. indicates the coefficients and SE is the standard error. Lag orders were chosen using AIC criterion
Table 10 Mean group estimation ARDL model
(Pre GFC, Year = 1995 to 2008)
Income Groups IMR U5MR
Long Short Long Short
LY HEPC −0.14* (.02) −0.29* (.14) − 0.14* (.02) −0.03*(.01)
LM HEPC −0.00 (.00) −0.06* (.02) − 0.00 (.00) - 0.06* (.02)
HM HEPC −0.001 (.00) −0.04* (.01) −.001 (.00) − 0.05* (.01)
HY HEPC −0.001* (.00) −0.12* (.01) − 0.00* (.00) −0.12* (.02)
(Post GFC, Year = 2009 to 2014)
Income Groups IMR U5MR
Long Short Long Short
LY HEPC −0.03*(.00) −0.13*(0.06) −0.01 (.005) − 0.14*(.06)
LM HEPC −.004* (.00) −0.03 (.02) −0.01* (.00) − 0.08* (.03)
HM HEPC −0.00* (0.00) −015*(.05) − 0.001*(.00) −0.11* (.05)
HY HEPC −0.00* (.00) −0.04* (.02) − 0.02* (.00) −0.16*(.08) 9(.04)(0.04)
Notes: Figures in brackets are the standard errors. * Significant at 5% confidence interval
Table 8 Mean group estimation ARDL model (with total factor productivity)
Income
Groups
Independent
variables
IMR MMR U5MR
Long Short Long Short Long Short
LY HEPC 0.49* (.15) −0.03*(.004) 1.7(2.6) −0.25*(.10) −0.42*(.10) −0.10*(.00)
N = 24 TFP −0.52 (.41) 0.003(.02) 1.2*(5.1) −0.21(.15) −4.1*(.38) 0.01*(.03)
LM HEPC −0.003*(.00) −0.05*(.01) − 0.01*(.00) − 0.01(0.01) − 0.01(.00) − 0.005(.02)
N = 32 TFP 0.04(.02) 0.00(.002) 0.21*(.03) − 0.13(0.07) 0.01(.02) 0.002(.01)
HM HEPC 0.01 (.001) − 0.01(.01) − 0.01*(.00) − 0.002(.00) 0.01*(.00) − 0.002(.01)
N = 22 TFP −0.18*(.07) 0.01*(.003) 0.15(.12) −0.05(.02) −0.02(.06) 0.01(.01)
HY HEPC −0.002*(.00) −0.001*(.01) − 0.003*(.00) −0.003*(.00) − 0.002*(.00) −0.001*(.00)
N = 37 TFP −0.01(.02) −0.002(.001) 0.02(.03) −0.02(.01) − 0.02(0.01) −0.001(.001)
Notes: Figures in brackets are the standard errors. * Significant at 5% confidence interval. N indicates number of countries in each income groups
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List of Countries included in the study
The countries in this study have been divided into four
groups according to the World Bank income group clas-
sifications. However, it is important to note that during
this twenty year period (1995–2014) many countries im-
proved their status from low-income to a comparatively
higher-income country. For simplification of the study a
country is considered a low-income country if for the
majority of the time period it was a low income country.
For instance, Ghana is currently a lower-middle income
country. But in this study Ghana is considered a low
income country as it was a low income country until the
year 2009. The classification of the countries are given
below:
1. High: Antigua and Barbuda, Australia, Austria, The Bahamas,
Bahrain, Barbados, Belgium, Brunei Darussalam, Canada,
Cyprus, Czech Republic, Denmark,Finland, France, Germany,
Greece, Iceland, Ireland, Israel, Italy, Japan, Rep. Korea,
Kuwait, Luxembourg, Malta, Netherlands, New Zealand,
Norway, Portugal, Qatar, Saudi Arabia, Singapore, Slovenia,
Spain, Sweden,Switzerland, Trinidad and Tobago, United
Arab Emirates, United Kingdom,United States.
2. Upper-
middle:
Argentina, Belarus, Belize, Botswana, Brazil, Bulgaria,
Chile, Costa Rica,Croatia, Cuba, Equatorial Guinea,
Estonia, Gabon, Grenada, Hungary, Latvia, Lebanon,
Lithuania, Malaysia, Mauritius, Mexico, Oman, Panama,
Poland, Romania, Russian Federation, Slovak Republic,
South Africa, St. Lucia, Turkey, Uruguay, Venezuela,.
3. Lower-
middle:
Albania, Algeria, Angola, Armenia, Azerbaijan, Bhutan,
Bolivia, Bosnia and Herzegovina, Cabo Verde, Cameroon,
China, Colombia, Rep. Congo,Djibouti, Dominican
Republic, Ecuador, Arab Rep. Egypt, El Salvador,
Fiji,Guatemala, Guyana, Honduras, Indonesia, Islamic Rep.
Iran, Jamaica, Jordan, Kazakhstan, Kiribati, FYR
Macedonia, Maldives, Moldova, Mongolia, Montenegro,
Morocco, Namibia, Nicaragua, Papua New Guinea,
Paraguay, Peru, Philippines, Samoa, Sri Lanka, Swaziland,
(Continued)
Thailand, Tonga, Tunisia, Turkmenistan, Ukraine,
Uzbekistan, Vietnam.
4. Low: Bangladesh, Benin, Burkina Faso, Burundi, Cambodia,
Chad, Comoros,Dem. Rep. Congo, Cote d’Ivoire, Eritrea,
Ethiopia, The Gambia, Ghana, Georgia, Guinea, Haiti, India,
Kenya, Kyrgyz Republic, Madagascar, Malawi, Mali,
Mauritania, Mozambique, Myanmar, Nepal, Niger, Nigeria,
Pakistan, Rwanda, Senegal, Sierra Leone, Sudan, Tajikistan,
Tanzania, Togo, Uganda, Rep. Yemen, Zambia.
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Table 11 Fully modified ordinary least squares test
(Pre GFC, Year = 1995 to 2008)
Income Groups IMR U5MR
Coef. SE Coef. SE
LY HEPC −0.20* 0.02 −0.26* 0.05
LM HEPC −0.04* 0.00 0.05* 0.01
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